JP2024534216A5 - - Google Patents

Info

Publication number
JP2024534216A5
JP2024534216A5 JP2024513920A JP2024513920A JP2024534216A5 JP 2024534216 A5 JP2024534216 A5 JP 2024534216A5 JP 2024513920 A JP2024513920 A JP 2024513920A JP 2024513920 A JP2024513920 A JP 2024513920A JP 2024534216 A5 JP2024534216 A5 JP 2024534216A5
Authority
JP
Japan
Prior art keywords
rna
mrna
aptamer
utr
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513920A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534216A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/058234 external-priority patent/WO2023031856A1/en
Publication of JP2024534216A publication Critical patent/JP2024534216A/ja
Publication of JP2024534216A5 publication Critical patent/JP2024534216A5/ja
Pending legal-status Critical Current

Links

JP2024513920A 2021-09-02 2022-09-01 Rnaアフィニティー精製のための組成物および方法 Pending JP2024534216A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163240027P 2021-09-02 2021-09-02
US63/240,027 2021-09-02
EP22315159 2022-07-20
EP22315159.8 2022-07-20
PCT/IB2022/058234 WO2023031856A1 (en) 2021-09-02 2022-09-01 Compositions and methods for rna affinity purification

Publications (2)

Publication Number Publication Date
JP2024534216A JP2024534216A (ja) 2024-09-18
JP2024534216A5 true JP2024534216A5 (enExample) 2025-09-08

Family

ID=83362521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513920A Pending JP2024534216A (ja) 2021-09-02 2022-09-01 Rnaアフィニティー精製のための組成物および方法

Country Status (5)

Country Link
US (1) US20240327847A1 (enExample)
EP (1) EP4396363A1 (enExample)
JP (1) JP2024534216A (enExample)
AU (1) AU2022336615A1 (enExample)
WO (1) WO2023031856A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022099003A1 (en) 2020-11-06 2022-05-12 Sanofi Lipid nanoparticles for delivering mrna vaccines
JP2025520538A (ja) 2022-06-17 2025-07-03 サノフィ パスツール インコーポレイテッド 環状rna親和性精製のための組成物及び方法
WO2025035120A1 (en) * 2023-08-10 2025-02-13 Board Of Regents, The University Of Texas System Aptamer-based purification of circular rnas

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4500707A (en) 1980-02-29 1985-02-19 University Patents, Inc. Nucleosides useful in the preparation of polynucleotides
US5132418A (en) 1980-02-29 1992-07-21 University Patents, Inc. Process for preparing polynucleotides
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4373071A (en) 1981-04-30 1983-02-08 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US4401796A (en) 1981-04-30 1983-08-30 City Of Hope Research Institute Solid-phase synthesis of polynucleotides
US5153319A (en) 1986-03-31 1992-10-06 University Patents, Inc. Process for preparing polynucleotides
US5262530A (en) 1988-12-21 1993-11-16 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5047524A (en) 1988-12-21 1991-09-10 Applied Biosystems, Inc. Automated system for polynucleotide synthesis and purification
US5700642A (en) 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
WO2004046321A2 (en) 2002-11-15 2004-06-03 Trustees Of Boston University Cis/trans riboregulators
WO2005106035A2 (en) 2004-04-09 2005-11-10 Cornell Research Foundation, Inc. Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use
EP2996697B1 (en) * 2013-05-15 2019-06-26 Robert Kruse Intracellular translation of circular rna
SG11201908043UA (en) * 2017-03-02 2019-09-27 Meiragtx Uk Ii Limited Regulation of gene expression by aptamer-modulated rnase p cleavage
FR3081169B1 (fr) * 2018-05-15 2020-06-19 Messenger Biopharma Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
KR20210149686A (ko) 2018-12-27 2021-12-09 라이프에디트 테라퓨틱스, 인크. 유전자 편집에 유용한 폴리펩티드 및 사용 방법

Similar Documents

Publication Publication Date Title
JP2024534216A5 (enExample)
CA3056756C (en) Method for producing complex of rna molecule and peptide, and utilization thereof
JP4808315B2 (ja) Dna・蛋白質融合体とその利用
Sousa et al. Improvement of transfection efficiency by using supercoiled plasmid DNA purified with arginine affinity chromatography
KR100713953B1 (ko) Rna-단백질 융합체를 이용한 단백질의 선별
JP2003505041A (ja) 固体支持体担体を用いる試験管内選択及びポリペプチドの任意の同定
JP2002513281A (ja) Rna−蛋白質の融合体を用いた蛋白質の選抜
JP2005522999A5 (enExample)
US20250263687A1 (en) Polynucleotide purification with monolith columns
CN102229932B (zh) 可识别hcv e1e2蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
EP3978510A1 (en) Norovirus-binding peptide
JP2005504517A5 (enExample)
JP2004526421A5 (enExample)
Bakayev et al. Subnucleosome particles containing high mobility group proteins HMG-E and HMG-G originate from transcriptionally active chromatin
CA2428438A1 (en) Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
CN120965875B (zh) 纳米抗体4c12及促进人白蛋白纯化的应用
JP2005507648A5 (enExample)
JP2020517280A5 (enExample)
Keck et al. cDNA cloning, recombinant expression and characterization of polypetides with exceptional DNA affinity
US20250207121A1 (en) METHODS FOR THE REMOVAL OF DOUBLE-AND/OR MULTI-STRANDED NUCLEIC ACID IMPURITIES FROM RNA PREPARATIONS BY LOW pH TREATMENT
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
JP2004097213A (ja) 核酸および/またはタンパク質の選択方法
JP2005516604A5 (enExample)
JP6478392B2 (ja) 核酸リンカー
JP2009542243A5 (enExample)